Barbell Medicine Podcast cover image

Q&A: Cholesterol Lowering, Volume vs. Intensity For Hypertrophy Volume, Zone 2 Efficiency, and More

Barbell Medicine Podcast

00:00

Statins vs PCSK9 Inhibitors for General Population

Dr. Jordan Feigenbaum explains LDL/ApoB risk, 'lower is better', and why statins are usually first-line over PCSK9 inhibitors.

Play episode from 00:38
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app